دورية أكاديمية
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma
العنوان: | Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma |
---|---|
المؤلفون: | De Jesus-Acosta, AnaAff1, Sugar, Elizabeth A., O’Dwyer, Peter J., Ramanathan, Ramesh K., Von Hoff, Daniel D., Rasheed, Zeshaan, Zheng, Lei, Begum, Asma, Anders, Robert, Maitra, Anirban, McAllister, Florencia, Rajeshkumar, N. V., Yabuuchi, Shinichi, de Wilde, Roeland F., Batukbhai, Bhavina, Sahin, Ismet, Laheru, Daniel A. |
المصدر: | British Journal of Cancer. 122(4):498-505 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 00070920 15321827 |
---|---|
DOI: | 10.1038/s41416-019-0683-3 |